At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 68 enrolled
Drug / intervention
Chlorhexidine gluconate +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Performance of a Chlorhexidine Antimicrobial Dressing
In Brief
A Phase 3 clinical trial evaluating Chlorhexidine gluconate and Transparent Adhesive Dressing for Catheterization. Completed, enrolled 68 participants.
Detailed Summary
Evaluate the clinical performance of a new IV Dressing in Comparison to a standard IV Dressing
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCatheterization
Countries--
CollaboratorsUniversity of Nebraska, 3M
Timeline
Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedAug 2007
Enrollment StartOct 2007
Primary CompletionDec 2007
Study CompletionJan 2008
TodayJul 2026
First PostedAug 16, 2007
Enrollment StartOct 1, 2007
Primary CompletionDec 1, 2007
Study CompletionJan 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 18.9 years ago
Interventions
Chlorhexidine gluconatedrug
2% Chlorhexidine Transparent Dressing applied as needed up to 7 days of wear
Transparent Adhesive Dressingdrug
Standard of Care Non-antimicrobial Transparent Adhesive Dressing applied as needed for up to 7 days of wear